Log In
Sign Up
Gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate; advanced renal cell carcinoma; advanced Pancreatic Neuroendocrine Tumors.
For gastrointestinal stromal tumor and advanced renal cell carcinoma: 50mg OD on a regime of 4 weeks on treatment followed by 2 weeks off. For advanced Pancreatic Neuroendocrine Tumors: 37.5mg OD on constinous basis
Mode of action
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us